Spots Global Cancer Trial Database for stage i pancreatic cancer ajcc v8

Every month we try and update this database with for stage i pancreatic cancer ajcc v8 cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study title	NCT ID	Conditions	Interventions	Eligibility	Organization
Monitoring Heart Rate Variability for the Early Detection of Pancreatic Cancer	NCT04400903	Pancreatic Duct... Stage I Pancrea... Stage IA Pancre... Stage IB Pancre...	Activity Monito... Quality-of-Life... Questionnaire A...	50 Years - 75 Years	OHSU Knight Cancer Institute
Monitoring Heart Rate Variability for the Early Detection of Pancreatic Cancer	NCT04400903	Pancreatic Duct... Stage I Pancrea... Stage IA Pancre... Stage IB Pancre...	Activity Monito... Quality-of-Life... Questionnaire A...	50 Years - 75 Years	OHSU Knight Cancer Institute
Real-Time Monitoring of Chemotherapy Side-Effects in Patients With Gastrointestinal Cancers, RT-CAMSS Study	NCT04449679	Clinical Stage ... Clinical Stage ... Clinical Stage ... Clinical Stage ... Clinical Stage ... Clinical Stage ... Clinical Stage ... Clinical Stage ... Clinical Stage ... Clinical Stage ... Clinical Stage ... Clinical Stage ... Clinical Stage ... Clinical Stage ... Clinical Stage ... Clinical Stage ... Clinical Stage ... Clinical Stage ... Clinical Stage ... Clinical Stage ... Clinical Stage ... Clinical Stage ... Clinical Stage ... Clinical Stage ... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Stage 0 Colorec... Stage 0 Pancrea... Stage I Colorec... Stage I Pancrea... Stage IA Pancre... Stage IB Pancre... Stage II Colore... Stage II Pancre... Stage IIA Color... Stage IIA Pancr... Stage IIB Color... Stage IIB Pancr... Stage IIC Color... Stage III Color... Stage III Pancr... Stage IIIA Colo... Stage IIIB Colo... Stage IIIC Colo... Stage IV Colore... Stage IV Pancre... Stage IVA Color... Stage IVB Color... Stage IVC Color...	Patient Monitor... Questionnaire A... Consultation	18 Years -	Thomas Jefferson University
NeoOPTIMIZE: Early Switching of mFOLFIRINOX or Gemcitabine/Nab-Paclitaxel Before Surgery for the Treatment of Resectable, Borderline Resectable, or Locally-Advanced Unresectable Pancreatic Cancer	NCT04539808	Pancreatic Aden... Stage 0 Pancrea... Stage I Pancrea... Stage III Pancr... Stage IV Pancre...	Capecitabine Fluorouracil Irinotecan Hydr... Leucovorin Calc... Losartan Potass... Oxaliplatin Radiation Thera... Resection Diagnostic Imag... Biospecimen Col...	18 Years -	OHSU Knight Cancer Institute
Gemcitabine, Cisplatin and Nab-Paclitaxel as Neoadjuvant Treatment for Patients With Resectable or Borderline Resectable Pancreatic Cancer	NCT06423326	Borderline Rese... Resectable Panc... Stage I Pancrea... Stage II Pancre... Stage III Pancr...	Biopsy Biospecimen Col... Cisplatin Computed Tomogr... Gemcitabine Magnetic Resona... Nab-paclitaxel Pancreatic Surg...	18 Years -	Emory University
A Study to Determine if the Drug, Pyrvinium Pamoate, is Safe and Tolerable in Patients With Pancreatic Cancer	NCT05055323	Resectable Panc... Stage 0 Pancrea... Stage I Pancrea... Stage IA Pancre... Stage IB Pancre... Stage II Pancre... Stage IIA Pancr... Stage IIB Pancr...	Pyrvinium Pamoa...	18 Years -	Thomas Jefferson University
Gemcitabine, Cisplatin and Nab-Paclitaxel as Neoadjuvant Treatment for Patients With Resectable or Borderline Resectable Pancreatic Cancer	NCT06423326	Borderline Rese... Resectable Panc... Stage I Pancrea... Stage II Pancre... Stage III Pancr...	Biopsy Biospecimen Col... Cisplatin Computed Tomogr... Gemcitabine Magnetic Resona... Nab-paclitaxel Pancreatic Surg...	18 Years -	Emory University

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

Join others from around the world: